Literature DB >> 3579610

Preparation and characterization of monoclonal antibodies to enteric adenovirus types 40 and 41.

J E Herrmann, D M Perron-Henry, D Stobbs-Walro, N R Blacklow.   

Abstract

We have prepared monoclonal antibodies to each of the enteric adenoviruses types 40 and 41. Three different hybridoma cell lines were selected which produced antibody found to react by radioimmunoprecipitation with adenovirus (Ad) hexon antigens. One was specific for Ad 40, another for Ad 41, and a third one reacted with both types. When tested in an enzyme immunoassay against all 41 known human Ad types, the type-specific monoclonal antibody against Ad 40 reacted homotypically, as did the monoclonal antibody against Ad 41. In addition, these monoclonal antibodies neutralized the homologous enteric Ad type. The monoclonal antibody which reacted with both enteric Ad types also showed lower levels of reactivity with the group C adenoviruses types 2, 5, and 6. The monoclonal antibodies produced will provide a definitive means for rapid identification of specific Ad types, and will be useful in defining the relationship of enteric adenoviruses to other types.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3579610     DOI: 10.1007/bf01310718

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  16 in total

1.  Grouping of monoclonal antibodies to adenovirus hexons by their cross-reactivity.

Authors:  E Adám; A Lengyel; M Takács; J Erdei; J Fachet; I Nász
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  Immunological relationships between hexons of certain human adenoviruses.

Authors:  E Norrby; G Wadell
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

3.  Delineation of antigenic determinants of adenovirus hexons by means of monoclonal antibodies.

Authors:  E Adám; J Erdei; A Lengyel; G Berencsi; J Fachet; I Nász
Journal:  Intervirology       Date:  1985       Impact factor: 1.763

4.  Comparison of a monoclonal antibody with a polyclonal serum in an enzyme-linked immunosorbent assay for detecting adenovirus.

Authors:  L J Anderson; E Godfrey; K McIntosh; J C Hierholzer
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

5.  Isolation and characterization of a slow-migrating class of adenovirus type 2 hexons.

Authors:  P Boulanger; C Devaux; P Lemay
Journal:  Virology       Date:  1978-02       Impact factor: 3.616

6.  Immunoprecipitation with two-dimensional pools as a hybridoma screening technique: production and characterization of monoclonal antibodies against adenovirus 2 proteins.

Authors:  C L Cepko; P S Changelian; P A Sharp
Journal:  Virology       Date:  1981-04-30       Impact factor: 3.616

7.  Characterization of anti-reovirus immunoglobulins secreted by cloned hybridoma cell lines.

Authors:  P W Lee; E C Hayes; W K Joklik
Journal:  Virology       Date:  1981-01-15       Impact factor: 3.616

8.  Development and application of monoclonal antibodies for specific detection of human enteric adenoviruses.

Authors:  N Singh-Naz; R K Naz
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

9.  Application of a solid-phase immunofluorometric assay to the selection of monoclonal antibody specific for the adenovirus group-reactive hexon antigen.

Authors:  J C Hierholzer; D J Phillips; D D Humphrey; R A Coombs; C B Reimer
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

10.  Adenovirus hexon monoclonal antibody that is group specific and potentially useful as a diagnostic reagent.

Authors:  C L Cepko; C A Whetstone; P A Sharp
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

View more
  9 in total

1.  Detection, typing, and subtyping of enteric adenoviruses 40 and 41 from fecal samples and observation of changing incidences of infections with these types and subtypes.

Authors:  J C de Jong; K Bijlsma; A G Wermenbol; M W Verweij-Uijterwaal; H G van der Avoort; D J Wood; A S Bailey; A D Osterhaus
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

2.  Prevalent enteric adenovirus variant not detected by commercial monoclonal antibody enzyme immunoassay.

Authors:  T Scott-Taylor; G Ahluwalia; B Klisko; G W Hammond
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

3.  Isolation and propagation of enteric adenoviruses in HEp-2 cells.

Authors:  D M Perron-Henry; J E Herrmann; N R Blacklow
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

4.  Incidence of enteric adenoviruses among children in Thailand and the significance of these viruses in gastroenteritis.

Authors:  J E Herrmann; N R Blacklow; D M Perron-Henry; E Clements; D N Taylor; P Echeverria
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

5.  Laboratory identification of adenoviruses associated with gastroenteritis in Canada from 1983 to 1986.

Authors:  M Brown
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

6.  Time-resolved fluoroimmunoassay for enteric adenoviruses using the europium chelator 4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid.

Authors:  M Brown; Y Shami; M Zywulko; N Singh-Naz; P J Middleton
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

7.  Conserved sequences of the adenovirus genome for detection of all human adenovirus types by hybridization.

Authors:  T H Scott-Taylor; G W Hammond
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

8.  Evaluation of a commercial monoclonal antibody-based enzyme immunoassay for detection of adenovirus types 40 and 41 in stool specimens.

Authors:  D J Wood; K Bijlsma; J C de Jong; C Tonkin
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

9.  Detection of enteric adenoviruses with synthetic oligonucleotide probes.

Authors:  T H Scott-Taylor; G Ahluwalia; M Dawood; G W Hammond
Journal:  J Med Virol       Date:  1993-12       Impact factor: 2.327

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.